Megestrol Acetate


w201



General information:


Withdrawn ID: w201
Canonical SMILES:
Standard InChI:
Standard InChIKey:
ATC class(es): G03AC05
G03DB02
L02AB01
Molecular Formula: C24H32O4
Molweight: 384.516



Withdrawal information:


Withdrawn due to drug safety reasons:Yes
First approved: 1963
First withdrawn: 1969
Last withdrawn: 1969
Reference: https://static-content.springer.com/esm/art%3A10.1186%2Fs12916-016-0553-2/MediaObjects/12916_2016_553_MOESM3_ESM.pdf



Side-effects:

Total reported cases (submitted by medical professionals) with Megestrol Acetate as primary suspect: 557


Reported final outcomes:
Hospitalization (initial or prolonged): 165
Death: 152
Life-Threatening condition: 40
Intervention required to prevent permanent impairment/damage: 11
Disability: 8


Reported side-effects:

Side-effect Case number
DEEP VEIN THROMBOSIS110
DEATH73
PULMONARY EMBOLISM57
ADRENAL INSUFFICIENCY44
MALIGNANT NEOPLASM PROGRESSION30
MENINGIOMA21
OEDEMA PERIPHERAL20
ASTHENIA19
NAUSEA16
DYSPNOEA16
THROMBOSIS15
HYPOTENSION13
DEHYDRATION13
WEIGHT INCREASED12
WEIGHT DECREASED12
DRUG INTERACTION12
CONFUSIONAL STATE12
ABDOMINAL PAIN12
BLOOD GLUCOSE INCREASED11
VOMITING10
FATIGUE10
DRUG INEFFECTIVE10
ABDOMINAL DISTENSION10
PNEUMONIA9
FALL9
DECREASED APPETITE9
HAEMOGLOBIN DECREASED8
DIARRHOEA8
ANAEMIA8
VAGINAL HAEMORRHAGE7
SECONDARY ADRENOCORTICAL INSUFFICIENCY7
UPPER GASTROINTESTINAL HAEMORRHAGE6
TACHYCARDIA6
RENAL FAILURE ACUTE6
PAIN IN EXTREMITY6
PAIN6
OEDEMA6
Intracranial pressure increased6
INCORRECT DOSE ADMINISTERED6
HYPONATRAEMIA6
CEREBROVASCULAR ACCIDENT6
BLOOD TESTOSTERONE DECREASED6
BLOOD CORTISOL DECREASED6
Steroid withdrawal syndrome5
SEPSIS5
RENAL FAILURE5
PYREXIA5
MEDICATION ERROR5
INTERNATIONAL NORMALISED RATIO INCREASED5
HYPOGONADISM5
HYPERKALAEMIA5
ERYTHEMA5
DIZZINESS5
CONDITION AGGRAVATED5
CHEST PAIN5
ADDISON'S DISEASE5
WHITE BLOOD CELL COUNT INCREASED4
SYNCOPE4
PULMONARY FIBROSIS4
Product use in unapproved indication4
MENTAL STATUS CHANGES4
INFECTION4
Idiopathic intracranial hypertension4
HOSPITALISATION4
HEART RATE INCREASED4
HAEMORRHAGE4
FAILURE TO THRIVE4
CHRONIC OBSTRUCTIVE PULMONARY DISEASE4
CACHEXIA4
ANOREXIA4
ANDROGEN DEFICIENCY4
ADRENAL SUPPRESSION4
UNRESPONSIVE TO STIMULI3
THROMBOCYTOPENIA3
SOMNOLENCE3
SINUS TACHYCARDIA3
RESPIRATORY ACIDOSIS3
PRODUCT TASTE ABNORMAL3
PRODUCT QUALITY ISSUE3
PITTING OEDEMA3
PANCREATIC CARCINOMA METASTATIC3
Off label use3
OESOPHAGITIS3
MYOCARDIAL INFARCTION3
METASTASES TO CENTRAL NERVOUS SYSTEM3
MELAENA3
MALAISE3
LUNG NEOPLASM MALIGNANT3
INTRACARDIAC THROMBUS3
HYPERTENSION3
HYPERHIDROSIS3
HYPERGLYCAEMIA3
HOT FLUSH3
GENERAL PHYSICAL HEALTH DETERIORATION3
GAIT DISTURBANCE3
DRUG HYPERSENSITIVITY3
DRUG DISPENSING ERROR3
DISORIENTATION3
DISEASE COMPLICATION3
CARDIOMYOPATHY3
CARDIAC MURMUR3
ASPIRATION3
ALOPECIA3
VIth nerve paralysis2
URINARY TRACT INFECTION2
TREATMENT NONCOMPLIANCE2
THROMBOPHLEBITIS2
Therapeutic product effect incomplete2
THERAPEUTIC AGENT TOXICITY2
Swelling2
STAPHYLOCOCCAL INFECTION2
SHOCK2
SEPTIC SHOCK2
Secondary hypogonadism2
RESPIRATORY DISTRESS2
RASH PRURITIC2
RASH2
Product prescribing error2
Product colour issue2
PROCEDURAL COMPLICATION2
POLLAKIURIA2
PNEUMOTHORAX2
PLATELET COUNT DECREASED2
OVERDOSE2
OSTEOPOROSIS2
ORTHOSTATIC HYPOTENSION2
ORAL INTAKE REDUCED2
ORAL CANDIDIASIS2
NEOPLASM MALIGNANT2
MUSCULAR WEAKNESS2
MOOD SWINGS2
MOBILITY DECREASED2
LUNG CANCER METASTATIC2
LOSS OF CONSCIOUSNESS2
LEUKOCYTOSIS2
ISCHAEMIC STROKE2
INTESTINAL OBSTRUCTION2
INTERNATIONAL NORMALISED RATIO DECREASED2
Incorrect product storage2
HYPOPHAGIA2
HYPOMAGNESAEMIA2
HYPOALBUMINAEMIA2
HEPATIC ENZYME INCREASED2
HEADACHE2
HAEMATEMESIS2
GASTROINTESTINAL HAEMORRHAGE2
GASTROINTESTINAL DISORDER2
FLUSHING2
ELECTROLYTE IMBALANCE2
ECCHYMOSIS2
EATING DISORDER2
DYSPNOEA EXERTIONAL2
DYSPHAGIA2
DRUG TOXICITY2
DIZZINESS POSTURAL2
DISEASE RECURRENCE2
DISEASE PROGRESSION2
DIABETES MELLITUS2
DEPRESSED MOOD2
DELIRIUM2
CORONARY ARTERY DISEASE2
CONVULSION2
CONSTIPATION2
COAGULOPATHY2
CHOKING2
CHEST X-RAY ABNORMAL2
CHEST DISCOMFORT2
CELLULITIS2
CATHETER RELATED INFECTION2
CARDIO-RESPIRATORY ARREST2
CARDIAC ARREST2
BREAST CANCER METASTATIC2
Breast cancer2
BLOOD SODIUM DECREASED2
BLOOD CHLORIDE DECREASED2
BLOOD ALBUMIN DECREASED2
BACK PAIN2
AZOTAEMIA2
ASPARTATE AMINOTRANSFERASE INCREASED2
ANGIOPATHY2
Aggression2
ABNORMAL BEHAVIOUR2
ABDOMINAL PAIN UPPER2
ABDOMINAL MASS2
WRONG DRUG ADMINISTERED1
Withdrawal syndrome1
WISKOTT-ALDRICH SYNDROME1
WHITE BLOOD CELLS URINE POSITIVE1
WHITE BLOOD CELL COUNT DECREASED1
WHEEZING1
WHEELCHAIR USER1
VITAMIN D DEFICIENCY1
VISUAL DISTURBANCE1
VENOUS THROMBOSIS LIMB1
VENOUS PRESSURE JUGULAR INCREASED1
URTICARIA1
URINE OUTPUT DECREASED1
URINE ODOUR ABNORMAL1
URINE LEUKOCYTE ESTERASE POSITIVE1
URINARY INCONTINENCE1
TREATMENT RELATED SECONDARY MALIGNANCY1
TREATMENT FAILURE1
TONGUE PARALYSIS1
THYROID FUNCTION TEST ABNORMAL1
THERAPEUTIC RESPONSE UNEXPECTED1
SYSTEMIC SCLEROSIS1
SWOLLEN TONGUE1
SUPRAVENTRICULAR TACHYCARDIA1
Subdural haemorrhage1
SUBCUTANEOUS EMPHYSEMA1
Subarachnoid haemorrhage1
STREPTOCOCCAL INFECTION1
Stomatitis1
STOMA SITE REACTION1
STAPHYLOCOCCAL SEPSIS1
SPINAL COMPRESSION FRACTURE1
SPEECH DISORDER1
SOFT TISSUE DISORDER1
SKIN ULCER1
SKIN STRIAE1
SINUSITIS1
SHOULDER PAIN1
SEROSITIS1
SEPSIS SYNDROME1
SEDATION1
SCLERODERMA1
SARCOMA UTERUS1
RHONCHI1
RETINAL DETACHMENT1
RESTRICTIVE PULMONARY DISEASE1
RESTLESSNESS1
RESPIRATORY RATE INCREASED1
RESPIRATORY FAILURE1
Respiratory alkalosis1
RENAL FAILURE CHRONIC1
RED BLOOD CELLS URINE POSITIVE1
RECTAL HAEMORRHAGE1
RASH GENERALISED1
RADIATION OESOPHAGITIS1
PULMONARY GRANULOMA1
PROTHROMBIN TIME PROLONGED1
Protein total decreased1
Product use issue1
Product physical consistency issue1
Product packaging confusion1
Product dose omission1
Product dispensing error1
PROCEDURAL SITE REACTION1
Prescribed underdose1
PREGNANCY1
POLYURIA1
PNEUMOMEDIASTINUM1
PLEURAL EFFUSION1
PHYSICAL ASSAULT1
PHLEBITIS1
PHARYNGOLARYNGEAL PAIN1
Pharyngeal swelling1
PHARYNGEAL MASS1
Peripheral artery occlusion1
PERICARDITIS TUBERCULOUS1
PERICARDIAL EFFUSION1
PERFORMANCE STATUS DECREASED1
PEPTIC ULCER1
Pelvic neoplasm1
Paraesthesia1
PAPILLOEDEMA1
PANCYTOPENIA1
Pancreatic pseudocyst1
Pancreatic disorder1
PANCREATIC CARCINOMA1
PALPITATIONS1
PALLOR1
Ovarian cancer1
OSTEOARTHRITIS1
OROPHARYNGEAL PAIN1
Oropharyngeal discomfort1
Obstructive airways disorder1
NOCTURIA1
NO THERAPEUTIC RESPONSE1
No adverse event1
NEUTROPENIA1
NEOPLASM PROGRESSION1
NECK PAIN1
Myositis1
Myopathy1
MYOCARDIAL ISCHAEMIA1
MYALGIA1
MUSCULOSKELETAL CHEST PAIN1
MULTI-ORGAN FAILURE1
MUCOSAL INFLAMMATION1
MOUTH ULCERATION1
MOOD ALTERED1
MICTURITION URGENCY1
METASTATIC RENAL CELL CARCINOMA1
METASTATIC CARCINOMA OF THE BLADDER1
METASTASES TO LIVER1
METASTASES TO KIDNEY1
METABOLIC ACIDOSIS1
MEMORY IMPAIRMENT1
Mastectomy1
Malabsorption1
LYMPHOMA1
Lymphoedema1
LYMPHADENOPATHY1
LUNG DISORDER1
LUNG CONSOLIDATION1
Loss of personal independence in daily activities1
LOCAL SWELLING1
Living in residential institution1
LIVER FUNCTION TEST ABNORMAL1
LIVER DISORDER1
LIQUID PRODUCT PHYSICAL ISSUE1
LIBIDO DECREASED1
LEUKOPENIA1
LARYNGEAL DISORDER1
LABORATORY TEST ABNORMAL1
KYPHOSIS1
Jugular vein thrombosis1
JOINT EFFUSION1
JAUNDICE1
INTRAOCULAR PRESSURE INCREASED1
Intracranial hypotension1
INTESTINAL STOMA COMPLICATION1
INTERSTITIAL LUNG DISEASE1
INTERNATIONAL NORMALISED RATIO FLUCTUATION1
INTERCEPTED MEDICATION ERROR1
Intercepted drug administration error1
Intentional product use issue1
INSOMNIA1
INCREASED APPETITE1
INADEQUATE ANALGESIA1
IMPAIRED WORK ABILITY1
HYPOVOLAEMIA1
Hypopituitarism1
HYPOCALCAEMIA1
HYPERTENSIVE CRISIS1
Hypersexuality1
HYPERCALCAEMIA1
HIP FRACTURE1
HEPATIC NEOPLASM MALIGNANT1
HEPATIC FAILURE1
HEPATIC ENCEPHALOPATHY1
HEMIANOPIA HOMONYMOUS1
HALLUCINATION1
HAEMATURIA1
HAEMATOMA1
HAEMATOCRIT DECREASED1
Haematochezia1
GYNAECOMASTIA1
GENERALISED OEDEMA1
GASTROINTESTINAL TUBE INSERTION1
FULL BLOOD COUNT DECREASED1
FOOD INTOLERANCE1
Folate deficiency1
FLUID RETENTION1
FLUID OVERLOAD1
FLATULENCE1
FEEDING TUBE COMPLICATION1
FAECES DISCOLOURED1
FAECALOMA1
FAECAL VOLUME DECREASED1
EXTRAPYRAMIDAL DISORDER1
Exposure during pregnancy1
ESCHERICHIA SEPSIS1
ERECTILE DYSFUNCTION1
Epistaxis1
EPIGLOTTIC OEDEMA1
ENTEROCUTANEOUS FISTULA1
Endometrial cancer metastatic1
Endometrial ablation1
EMPHYSEMA1
EMBOLISM1
DYSURIA1
DYSPNOEA EXACERBATED1
DYSPEPSIA1
Dysgeusia1
DRY SKIN1
DRY MOUTH1
DRUG LEVEL INCREASED1
DRUG INTOLERANCE1
DISTURBANCE IN ATTENTION1
DIABETES MELLITUS INADEQUATE CONTROL1
DEVICE RELATED INFECTION1
DEPRESSION1
DEPRESSED LEVEL OF CONSCIOUSNESS1
DEMENTIA1
CYSTITIS ESCHERICHIA1
CUSHINGOID1
CREATININE RENAL CLEARANCE DECREASED1
COUGH1
CONTUSION1
COGNITIVE DISORDER1
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR1
CHRONIC OBSTRUCTIVE AIRWAYS DISEASE EXACERBATED1
CHONDROCALCINOSIS1
CHOLESTASIS1
CEREBROVASCULAR DISORDER1
Cerebral venous thrombosis1
CEREBRAL ISCHAEMIA1
CEREBRAL INFARCTION1
CEREBRAL ATROPHY1
CEREBELLAR SYNDROME1
CATHETER RELATED COMPLICATION1
CARDIOPULMONARY FAILURE1
CARDIOMEGALY1
CARDIAC FAILURE HIGH OUTPUT1
CARDIAC FAILURE CONGESTIVE1
CARDIAC DISORDER1
CANDIDIASIS1
BRONCHOPLEURAL FISTULA1
BRONCHITIS1
BRONCHIECTASIS1
BREATH SOUNDS ABNORMAL1
BODY TEMPERATURE INCREASED1
BLOOD URINE PRESENT1
BLOOD UREA INCREASED1
BLOOD TESTOSTERONE INCREASED1
BLOOD PRESSURE SYSTOLIC INCREASED1
BLOOD POTASSIUM DECREASED1
BLOOD LUTEINISING HORMONE DECREASED1
BLOOD GLUCOSE DECREASED1
BLOOD CREATININE INCREASED1
BLOOD CREATININE DECREASED1
BLOOD CORTISOL ABNORMAL1
BLOOD BILIRUBIN INCREASED1
BLOOD ALKALINE PHOSPHATASE INCREASED1
BLOOD ACID PHOSPHATASE INCREASED1
BLINDNESS UNILATERAL1
Blindness1
BLADDER OBSTRUCTION1
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION1
BENIGN INTRACRANIAL HYPERTENSION1
BALANCE DISORDER1
BACTERIAL TEST POSITIVE1
BACK INJURY1
Axillary lymphadenectomy1
ATRIAL FIBRILLATION1
ASTHMA1
ASCITES1
ARTHRALGIA1
AREFLEXIA1
Aortic thrombosis1
ANXIETY1
ANTICONVULSANT DRUG LEVEL INCREASED1
ANGIOEDEMA1
ANGER1
Anaphylactic reaction1
Anaemia megaloblastic1
AMENORRHOEA1
ALTERED STATE OF CONSCIOUSNESS1
ALANINE AMINOTRANSFERASE INCREASED1
ALANINE AMINOTRANSFERASE DECREASED1
AGITATION1
ADVERSE EVENT1
ADRENAL NEOPLASM1
Acute respiratory failure1
ACUTE MYOCARDIAL INFARCTION1
ACTIVITIES OF DAILY LIVING IMPAIRED1
ACIDOSIS1
ACCIDENTAL EXPOSURE1
ABORTION SPONTANEOUS1
ABDOMINAL PAIN LOWER1
Abdominal discomfort1
ABASIA1





Filtered ChEMBL targets:

Target UniProtKB ID Activity in nm Target Name Target gene
P02545 8912.5 Prelamin-A/C LMNA_HUMAN
Q16637 1258.9 Survival motor neuron protein SMN_HUMAN
Q16665 7943.3 Hypoxia-inducible factor 1-alpha HIF1A_HUMAN
Q6W5P4 3162.3 Neuropeptide S receptor NPSR1_HUMAN



Toxicity information:

Toxicity class: 5
Toxicity type: carcinogenicity
LD50: 5000 mg/kg



External links:

ChEBML: CHEMBL1201139
DrugBank: DB00351